Pfizer finalizes Metsera buy after contentious bidding war with Novo Nordisk
13th November 2025 Uncategorised 0Signed, sealed and delivered, Metsera is finally Pfizer’s. Pfizer has completed its acquisition of the obesity biotech, capping a whirlwind two weeks in which rival pharma Novo Nordisk attempted to swoop in and snatch the startup from under Pfizer’s nose.
More: Pfizer finalizes Metsera buy after contentious bidding war with Novo Nordisk
Source: fierce